摘要
目的:观察ω-3脂肪酸在胃癌新辅助化疗患者术后康复中的作用。方法:选择进展期胃癌40例,采用mFOLFOX-6方案术前化疗2周期,对照组(20例)术后常规治疗,治疗组(20例),术前1d及术后6d加用ω-3脂肪酸,观察两组患者手术后康复有无差异。结果:两组患者术后2、4、6dC反应蛋白(CRP)比较,差异具有统计学意义;两组患者手术后2、4、6dSIRS(全身炎症反应综合征)发生率,切口感染、吻合口瘘发生率,及术后静脉导管相关感染、血液感染及肺部感染率比较,差异无统计学意义(P>0.05)。结论:ω-3脂肪酸能降低患者炎症反应,促进患者康复。
Objective:To evaluate the efficacy of Fatty Acids Omega-3 to postoperative rehabilitation in gastric cancer undergoing neoadjuvant chemotherapy.Methods:Patients with previously untreated advanced gastric cancer received mFOLFOX-6 neoadjuvant chemotherapy;twenty patients received Fatty Acids Omega-3 from one day preoperative to six days of postoperative the patients in the control group received basic treatment.Results:The difference of CRP 2,4,6 day of postoperative between two groups was statistically significant.Conclusion:Fatty Acids Omega-3 can degrade inflammatory reaction and encourage rehabilitation of gastric cancer undergoing neoadjuvant chemotherapy.
出处
《中国当代医药》
2011年第25期13-15,共3页
China Modern Medicine
关键词
进展期胃癌
新辅助化疗
氟尿嘧啶
奥沙利铂
根治术
Ω-3脂肪酸
Gastric cancer
Neoadjuvant chemotherapy
Fluorouracil
Oxaliplatin
Radical correction
Fatty Acids Omega-3